| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.24 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.07 |